rs4474514

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000899.5(KITLG):​c.16-14317C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.659 in 152,100 control chromosomes in the GnomAD database, including 36,712 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.66 ( 36712 hom., cov: 32)

Consequence

KITLG
NM_000899.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.763

Publications

46 publications found
Variant links:
Genes affected
KITLG (HGNC:6343): (KIT ligand) This gene encodes the ligand of the tyrosine-kinase receptor encoded by the KIT locus. This ligand is a pleiotropic factor that acts in utero in germ cell and neural cell development, and hematopoiesis, all believed to reflect a role in cell migration. In adults, it functions pleiotropically, while mostly noted for its continued requirement in hematopoiesis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
KITLG Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 69
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hyperpigmentation with or without hypopigmentation, familial progressive
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial progressive hyper- and hypopigmentation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial progressive hyperpigmentation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Waardenburg syndrome type 2
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, G2P
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • Waardenburg syndrome, IIa 2F
    Inheritance: AR, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.794 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000899.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KITLG
NM_000899.5
MANE Select
c.16-14317C>T
intron
N/ANP_000890.1P21583-1
KITLG
NM_003994.6
c.16-14317C>T
intron
N/ANP_003985.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KITLG
ENST00000644744.1
MANE Select
c.16-14317C>T
intron
N/AENSP00000495951.1P21583-1
KITLG
ENST00000347404.10
TSL:1
c.16-14317C>T
intron
N/AENSP00000054216.5P21583-2
KITLG
ENST00000874530.1
c.16-14317C>T
intron
N/AENSP00000544589.1

Frequencies

GnomAD3 genomes
AF:
0.659
AC:
100140
AN:
151982
Hom.:
36708
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.303
Gnomad AMI
AF:
0.752
Gnomad AMR
AF:
0.782
Gnomad ASJ
AF:
0.857
Gnomad EAS
AF:
0.722
Gnomad SAS
AF:
0.804
Gnomad FIN
AF:
0.784
Gnomad MID
AF:
0.854
Gnomad NFE
AF:
0.800
Gnomad OTH
AF:
0.698
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.659
AC:
100164
AN:
152100
Hom.:
36712
Cov.:
32
AF XY:
0.664
AC XY:
49363
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.302
AC:
12521
AN:
41448
American (AMR)
AF:
0.782
AC:
11957
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.857
AC:
2977
AN:
3472
East Asian (EAS)
AF:
0.722
AC:
3740
AN:
5180
South Asian (SAS)
AF:
0.806
AC:
3889
AN:
4828
European-Finnish (FIN)
AF:
0.784
AC:
8286
AN:
10572
Middle Eastern (MID)
AF:
0.857
AC:
252
AN:
294
European-Non Finnish (NFE)
AF:
0.800
AC:
54380
AN:
67992
Other (OTH)
AF:
0.699
AC:
1476
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1395
2790
4185
5580
6975
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
774
1548
2322
3096
3870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.761
Hom.:
154695
Bravo
AF:
0.640
Asia WGS
AF:
0.726
AC:
2525
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
5.5
DANN
Benign
0.54
PhyloP100
0.76
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4474514; hg19: chr12-88953959; API